Filter
579
Text search:
laboratory
biosafety
Featured
Recommendations
97
New Publications
135
Language
Document type
No document type
271
Guidelines
145
Studies & Reports
59
Manuals
56
Strategic & Response Plan
25
Training Material
8
Fact sheets
6
Situation Updates
5
Resource Platforms
3
Brochures
1
Countries / Regions
India
33
Sierra Leone
17
Latin America and the Carribbean
17
Western and Central Europe
17
Nigeria
16
Africa
16
Global
14
Kenya
12
Ghana
11
Rwanda
11
Eastern Europe
11
Uganda
10
Brazil
10
Liberia
9
Zambia
8
West and Central Africa
8
Ethiopia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Congo, Democratic Republic of
5
Nepal
5
South–East Asia Region
5
Russia
5
Syria
4
Namibia
4
Eastern Europe and Central Asia
4
Spain
4
Guinea
3
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
203
Pharmacy & Technologies
59
Clinical Guidelines
50
Key Resources
24
Public Health
21
Women & Child Health
6
Capacity Building
3
Toolboxes
COVID-19
127
TB
104
Ebola & Marburg
60
Rapid Response
60
2.0 Rapid Response
42
AMR
37
NTDs
21
HIV
14
Zika
12
Conflict
9
Polio
8
Caregiver
8
Pharmacy
7
Planetary Health
6
Natural Hazards
4
Specific Hazards
4
Cholera
3
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Malaria
2
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-
...
Biosafety involves the implementation of containment principles, technologies and practices to prevent unintentional exposure to biological agents. Biosecurity involves the protection, control and accountability of biological materials and informati
...
Given the current situation of the COVID-19 pandemic, countries are advised to continue adopting the TB diagnostic algorithms recommended by PAHO / WHO.
Despite the differences in the modes of transmission of TB and COVID-19, certain personal protection measures are relevant for both diseases. Rout
...
Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towar
...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health resea
...
WHO has developed this manual in order to strengthen the laboratory diagnosis and virological surveillance of influenza infection.
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p
...
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member Stat
...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. Th
...
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepati ...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepati ...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato
...
